7.26
price up icon2.40%   0.17
after-market 시간 외 거래: 7.18 -0.08 -1.10%
loading
전일 마감가:
$7.09
열려 있는:
$7.02
하루 거래량:
1.75M
Relative Volume:
0.75
시가총액:
$2.00B
수익:
$248.37M
순이익/손실:
$11.74M
주가수익비율:
-38.21
EPS:
-0.19
순현금흐름:
$18.24M
1주 성능:
+5.68%
1개월 성능:
+11.86%
6개월 성능:
+65.38%
1년 성능:
+83.33%
1일 변동 폭
Value
$7.01
$7.30
1주일 범위
Value
$6.7745
$7.325
52주 변동 폭
Value
$3.17
$7.325

맨카인드 Stock (MNKD) Company Profile

Name
명칭
Mannkind Corp
Name
전화
818-661-5000
Name
주소
1 CASPER STREET, DANBURY, CA
Name
직원
414
Name
트위터
@MannKindCorp
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
MNKD's Discussions on Twitter

맨카인드 Stock (MNKD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-10-10 개시 Wedbush Outperform
2021-05-14 개시 RBC Capital Mkts Sector Perform
2019-12-24 개시 Oppenheimer Outperform
2019-10-25 개시 Cantor Fitzgerald Overweight
2019-05-14 개시 BTIG Research Buy
2019-03-04 개시 SVB Leerink Outperform
2019-02-22 개시 SVB Leerink Outperform
2018-02-28 다운그레이드 Maxim Group Hold → Sell
2017-11-01 다운그레이드 Maxim Group Buy → Hold
2017-10-10 개시 H.C. Wainwright Buy
2017-10-06 재확인 Maxim Group Buy
2017-08-11 개시 Maxim Group Buy
2016-05-10 재확인 Piper Jaffray Underweight
2016-05-10 재확인 RBC Capital Mkts Underperform
2016-01-06 재확인 Piper Jaffray Underweight
2016-01-06 재확인 RBC Capital Mkts Underperform
2015-11-04 다운그레이드 RBC Capital Mkts Outperform → Underperform
2015-09-09 다운그레이드 Piper Jaffray Neutral → Underweight
2015-08-03 재확인 RBC Capital Mkts Outperform
2015-05-11 다운그레이드 JP Morgan Neutral → Underweight
2015-05-11 재확인 MLV & Co Hold
2015-04-16 재확인 RBC Capital Mkts Outperform
모두보기

맨카인드 주식(MNKD)의 최신 뉴스

pulisher
Nov 04, 2024

MannKind (NASDAQ:MNKD) Reaches New 1-Year HighHere's What Happened - MarketBeat

Nov 04, 2024
pulisher
Nov 02, 2024

MannKind Shares Soar to Over 8-Year Highs on United Therapeutics’ Tyvaso Revenue Surge: Retail Is Optimistic - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

MannKind Corporation (MNKD) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease - ForexTV.com

Oct 31, 2024
pulisher
Oct 29, 2024

MannKind (NASDAQ:MNKD) Sets New 1-Year HighTime to Buy? - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

MannKind stock soars to 52-week high, touches $6.93 - Investing.com

Oct 29, 2024
pulisher
Oct 17, 2024

MannKind Co. (NASDAQ:MNKD) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

MannKind Corporation Reports 2012 Fourth Quarter and Full Year Financial Results - AOL

Oct 16, 2024
pulisher
Oct 16, 2024

SG Americas Securities LLC Takes Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Mannkind Corp (MNKD) receives an Outperform rating from Leerink Partners - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Recent Insider Activity Could Benefit 3M Co. (MMM) - Knox Daily

Oct 15, 2024
pulisher
Oct 14, 2024

Holdings of Mannkind Corp (MNKD) are aligned with the stars - SETE News

Oct 14, 2024
pulisher
Oct 11, 2024

Selling Buzz: Mannkind Corp [MNKD] Chief People & Workpl Officer Tross Stuart A sells 25,000 shares of the company - Knox Daily

Oct 11, 2024
pulisher
Oct 10, 2024

Ratios Revealed: Decoding Mannkind Corp (MNKD)’s Financial Health - The Dwinnex

Oct 10, 2024
pulisher
Oct 09, 2024

MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ... By GuruFocus - Investing.com Canada

Oct 09, 2024
pulisher
Oct 09, 2024

MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Re - GuruFocus.com

Oct 09, 2024
pulisher
Oct 09, 2024

Did Mannkind Corp (MNKD) perform well in the last session? - US Post News

Oct 09, 2024
pulisher
Oct 08, 2024

Potential Price Increase for Mannkind Corp (MNKD) After Recent Insider Activity - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Mannkind Corp (MNKD) can make a big difference with a little luck - SETE News

Oct 08, 2024
pulisher
Oct 08, 2024

Squarepoint Ops LLC Sells 133,926 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

Why MannKind (MNKD) Could Beat Earnings Estimates Again - Yahoo Finance

Oct 07, 2024
pulisher
Oct 04, 2024

MannKind (MNKD) Just Overtook the 20-Day Moving Average - Yahoo Finance

Oct 04, 2024
pulisher
Oct 04, 2024

MannKind Co. (NASDAQ:MNKD) Shares Purchased by Millennium Management LLC - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Exploring High Growth Tech Stocks In The United States October 2024 - Yahoo Finance

Oct 04, 2024
pulisher
Oct 03, 2024

MannKind (NASDAQ:MNKD) Shares Up 3.2% - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

MannKind Leverages Tyvaso DPI Strength In Pulmonary Market Expansion - Seeking Alpha

Oct 03, 2024
pulisher
Oct 03, 2024

Marshall Wace LLP Sells 205,764 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat

Oct 03, 2024
pulisher
Oct 01, 2024

A better buy-in window may exist right now for Mannkind Corp (MNKD) - SETE News

Oct 01, 2024
pulisher
Sep 30, 2024

MannKind's SWOT analysis: inhaled therapeutics firm's stock shows promise amid challenges - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

More Adults With Type 1 Diabetes Achieved A1C Goal ( - Yahoo Finance

Sep 30, 2024
pulisher
Sep 26, 2024

MannKind Co. (NASDAQ:MNKD) Shares Bought by Dark Forest Capital Management LP - MarketBeat

Sep 26, 2024
pulisher
Sep 26, 2024

Mannkind Corp (MNKD)’s results reveal risk - US Post News

Sep 26, 2024
pulisher
Sep 24, 2024

The Attractiveness of Investing In Mind Medicine Inc (MNMD) is Growing - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

A new trading data show Mannkind Corp (MNKD) is showing positive returns. - SETE News

Sep 24, 2024
pulisher
Sep 24, 2024

MNKD stock rated an Outperform by Leerink Partners - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Closing Figures: Mind Medicine Inc (MNMD)’s Negative Finish at 5.87, Down -1.68 - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

Manba Finance IPO Sees Stellar 73.18 Times Subscription on Second Day - Devdiscourse

Sep 24, 2024
pulisher
Sep 24, 2024

Manba Finance IPO subscribed 73.18 times on Day 2 amid heavy demand from institutional investors - NewsDrum

Sep 24, 2024
pulisher
Sep 24, 2024

Latest News - LatestLY

Sep 24, 2024
pulisher
Sep 24, 2024

Mind Medicine Inc (MNMD) produces promising results - US Post News

Sep 24, 2024
pulisher
Sep 24, 2024

Stock market update: Nifty Pharma index advances 0.23% - The Economic Times

Sep 24, 2024
pulisher
Sep 24, 2024

Manba Finance IPO continues to attract great interest, subscribed 73 times on day 2 - Moneycontrol

Sep 24, 2024
pulisher
Sep 24, 2024

Manba Finance IPO subscribed 56 times so far on Day 2 - Indiainfoline

Sep 24, 2024
pulisher
Sep 24, 2024

Manba Finance IPO Day 2: Issue subscribed 41.11 times so far, check key dates and more - Upstox

Sep 24, 2024
pulisher
Sep 24, 2024

Manaba Finance IPO Day 2: Check latest subscription, expected listing gains - India Today

Sep 24, 2024
pulisher
Sep 24, 2024

Mankind Pharma To Raise Rs 7,000-Crore Debt For Bharat Serums Acquisition - NDTV Profit

Sep 24, 2024
pulisher
Sep 23, 2024

Stock to buy today: Mankind Pharma (₹2,651.30): BUY - BusinessLine

Sep 23, 2024
pulisher
Sep 23, 2024

Trade Spotlight: How should you trade Siemens, Mankind Pharma, Kotak Bank, DLF, Indegene and others on... - Moneycontrol

Sep 23, 2024
pulisher
Sep 23, 2024

Avoro Capital Advisors LLC Reduces Stock Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Manba Finance Limited IPO Subscribed 23.67 Times on Day 1 of Bidding, Sale To Conclude on September 25; - LatestLY

Sep 23, 2024

맨카인드 (MNKD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):